Study Offers Support For Biosimilar-To-Biosimilar Switching
Practice Is Safe And Effective, But Not Covered By Current Regulations Or Guidance
A new paper has examined the issue of biosimilar-to-biosimilar switching, concluding that it is a safe and effective clinical practice but highlighting a lack of current health authority regulations or guidance on the subject.
